Overview
-
Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
₹17.82
▼ 0.02
(0.11%)
| Instrument Name | Watchlist | Investment Date | % Holding | No of Units | Value (₹ Cr) | Asset Type | Industry Name |
|---|---|---|---|---|---|---|---|
 Divis Laboratories Ltd | 31 Aug 2026 | 8.45% | 80,514 | ₹76.22 Cr | Equity | Pharmaceuticals | |
 Sun Pharmaceutical ... | 31 Aug 2026 | 7.40% | 3,36,271 | ₹66.74 Cr | Equity | Pharmaceuticals | |
 Torrent Pharmaceuti... | 31 Aug 2026 | 6.78% | 1,20,829 | ₹61.21 Cr | Equity | Pharmaceuticals | |
 Apollo Hospitals En... | 31 Aug 2026 | 4.73% | 47,982 | ₹42.70 Cr | Equity | Healthcare | |
 Laurus Labs Ltd | 31 Aug 2026 | 3.78% | 1,78,307 | ₹34.15 Cr | Equity | Pharmaceuticals | |
| Sai Life Sciences Ltd | 31 Aug 2026 | 3.32% | 2,05,281 | ₹29.96 Cr | Equity | Pharmaceuticals | |
 Cipla Ltd | 31 Aug 2026 | 3.25% | 2,08,361 | ₹29.36 Cr | Equity | Pharmaceuticals | |
 Max Healthcare Inst... | 31 Aug 2026 | 3.05% | 2,64,034 | ₹27.52 Cr | Equity | Healthcare | |
 Neuland Laboratorie... | 31 Aug 2026 | 2.88% | 11,278 | ₹25.95 Cr | Equity | Pharmaceuticals | |
 Ipca Laboratories Ltd | 31 Aug 2026 | 2.66% | 1,21,418 | ₹23.98 Cr | Equity | Pharmaceuticals |
Funds in the same category by AUM
You can invest in WhiteOak Capital Pharma and Healthcare Fund-Dir (G) through a lump sum investment or a monthly SIP. The minimum lump sum investment is ₹500 and the minimum SIP amount is ₹100.
The latest NAV of WhiteOak Capital Pharma and Healthcare Fund-Dir (G) is ₹17.82.
WhiteOak Capital Pharma and Healthcare Fund-Dir (G) manages assets worth ₹902.24 Cr.
The expense ratio of WhiteOak Capital Pharma and Healthcare Fund-Dir (G) is 1.13%.
The exit load applicable on WhiteOak Capital Pharma and Healthcare Fund-Dir (G) is NIL..
As per the riskometer, WhiteOak Capital Pharma and Healthcare Fund-Dir (G) carries Very High risk.
WhiteOak Capital Pharma and Healthcare Fund-Dir (G) is managed by WhiteOak Capital Mutual Fund.
WhiteOak Capital Pharma and Healthcare Fund-Dir (G) belongs to the Sectoral Fund category.
WhiteOak Capital Pharma and Healthcare Fund-Dir (G) is benchmarked against the BSE Healthcare TRI.
WhiteOak Capital Pharma and Healthcare Fund-Dir (G) has no lock-in period, so units can be redeemed at any time subject to the applicable exit load.
WhiteOak Capital Pharma and Healthcare Fund-Dir (G) was launched on 06 Feb 2024.
After the initial investment, you can invest in WhiteOak Capital Pharma and Healthcare Fund-Dir (G) in further multiples of ₹500.
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. However, there can be no assurance that the investment objective of the Scheme will be realized.
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. However, there can be no assurance that the investment objective of the Scheme will be realized.
06 Feb 2024
₹902.24 Cr
₹17.82
₹100
₹500
Very High
1.13%
19.86
0.66
1.14
4.69
0.53
0.15
1.85
NIL.
This fund has Very High risk.
Returns over a year are annualised (per year, compounded).
Calendar year return from the first period shown through each year.
| Company | Watchlist | Sector | Activity | Investment Date | % Holding | Market Value | Shares | Asset Type | Rating |
|---|---|---|---|---|---|---|---|---|---|
| Molbio Diagnostics Ltd | Medical Equipment | Bought | 31 Aug 2026 | 0.98% | ₹8.85 Cr | 81,504 | Equity | EQUITY | |
 Bharat Parenterals Ltd | Pharmaceuticals -... | Bought | 31 Aug 2026 | 0.04% | ₹0.39 Cr | 2,530 | Equity | EQUITY | |
| TBILL-364D | T Bills | Bought | 31 Aug 2026 | 0.01% | ₹0.10 Cr | 10,000 | T Bills | Sovereign | |
| Torrent Pharmaceuti... | Pharmaceuticals -... | Bought | 31 Jul 2026 | 7.81% | ₹64.45 Cr | 1,25,810 | Equity | EQUITY | |
 Granules India Ltd | Pharmaceuticals -... | Sold | 31 Jul 2026 | 1.56% | ₹12.89 Cr | 1,56,353 | Equity | EQUITY | |
| Global Health Ltd | Hospitals / Medic... | Bought | 31 Jul 2026 | 1.18% | ₹9.75 Cr | 69,387 | Equity | EQUITY | |
| Manipal Health Ente... | Hospitals / Medic... | Bought | 31 Jul 2026 | 0.97% | ₹8.00 Cr | 1,35,600 | Equity | EQUITY | |
| Biocon Ltd | Biotechnology | Bought | 31 Jul 2026 | 0.54% | ₹4.49 Cr | 1,05,395 | Equity | EQUITY | |
 J B Chemicals & Pha... | Pharmaceuticals -... | Sold | 30 Jun 2026 | 6.94% | ₹51.48 Cr | 2,24,216 | Equity | EQUITY | |
| Glenmark Pharmaceut... | Pharmaceuticals -... | Sold | 30 Jun 2026 | 1.17% | ₹8.69 Cr | 39,416 | Equity | EQUITY |
| Fund | 1Y | 3Y | Expense Ratio | Fund Size | Alpha | Sharpe | Risk | |
|---|---|---|---|---|---|---|---|---|
 SBI Healthcare Opportunities ... | 22.78% | 24.99% | 1.04% | ₹5,796.42 Cr | 17.41 | 1.27 | Very High | |
 HDFC Pharma and Healthcare Fu... | 28.36% | — | 1.08% | ₹3,310.64 Cr | 24.17 | 1.58 | Very High | |
 Tata India Pharma & Healthcar... | 10.30% | 20.72% | 1.00% | ₹1,565.28 Cr | 14.43 | 0.95 | Very High | |
 UTI-Healthcare Fund - Direct (G) | 18.79% | 25.04% | 1.26% | ₹1,443.57 Cr | 17.68 | 1.17 | Very High | |
 Aditya Birla SL Pharma & Heal... | 19.32% | 22.43% | 1.02% | ₹1,102.73 Cr | 16.00 | 1.10 | Very High | |
| WhiteOak Capital Pharma and H... | 24.81% | — | 1.13% | ₹902.24 Cr | 19.86 | 1.14 | Very High | |
 LIC MF Healthcare Fund - Dire... | 18.08% | 23.67% | 1.42% | ₹103.11 Cr | 16.82 | 1.12 | Very High |
Funds in the same category by AUM
| Fund | Watchlist | AMC | NAV | Fund Size | Expense Ratio | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|
 ICICI Pru Technology Fund... | ICICI Prudential Mutual Fund | ₹194.12 | ₹13,660.98 Cr | 1.22% | -11.08% | 4.46% | 1.93% | |
| HDFC Defence Fund - Direc... | HDFC Mutual Fund | ₹31.08 | ₹11,477.59 Cr | 0.89% | 23.83% | 38.03% | — | |
| ICICI Pru Banking & Finan... | ICICI Prudential Mutual Fund | ₹145.07 | ₹11,330.58 Cr | 1.23% | -3.67% | 9.21% | 8.98% | |
| SBI Banking & Financial S... | SBI Mutual Fund | ₹47.70 | ₹10,872.95 Cr | 1.20% | -0.70% | 14.93% | 11.76% | |
| Tata Digital India Fund -... | Tata Mutual Fund | ₹46.47 | ₹10,322.02 Cr | 0.67% | -13.66% | 3.50% | 1.77% | |
| WhiteOak Capital Pharma a... | WhiteOak Capital Mutual Fund | ₹17.82 | ₹902.24 Cr | 1.13% | 24.81% | — | — |